Indegene Limited (NSE:INDGN)
India
· Delayed Price · Currency is INR 571.75
+3.75 (0.66%)
May 13, 2025, 3:30 PM IST
Indegene Revenue
In the fiscal year ending March 31, 2025, Indegene had annual revenue of 28.39B INR with 9.64% growth. Indegene had revenue of 7.56B in the quarter ending March 31, 2025, with 12.28% growth.
Revenue
28.39B
Revenue Growth
+9.64%
P/S Ratio
4.82
Revenue / Employee
6.50M
Employees
4,367
Market Cap
136.80B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |